The global implications of diabetes and cancer

The Lancet

Volumn 383, Issue 9933, 2014, Pages 1947-1948

  Shi, Yuankai ^a,b,c   Hu, Frank B ^d,e  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b National Center for Anticancer Drugs Clinical Study   (China)

^c Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs   (China)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; C REACTIVE PROTEIN; DIPEPTIDYL PEPTIDASE IV INHIBITOR; ESTROGEN; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; GLUCOSE; INSULIN; INSULIN GLARGINE; INSULIN RECEPTOR; INTERLEUKIN 6; METFORMIN; SEX HORMONE; SEX HORMONE BINDING GLOBULIN; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA;

AFRICA; AGING; ASSOCIATION; BLADDER CANCER; BREAST CANCER; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CARCINOGENESIS; CENTRAL AMERICA; CHINA; DIABETES MELLITUS; DIABETIC PATIENT; DOWN REGULATION; ENDOMETRIUM CANCER; EPIDEMIC; GLUCONEOGENESIS; HIGH RISK POPULATION; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; INDIA; INSULIN SENSITIVITY; INSULIN TREATMENT; LETTER; LIFESTYLE MODIFICATION; LIVER CANCER; LOWEST INCOME GROUP; MEDICAL SOCIETY; NEOPLASM; OBESITY; OVARY CANCER; PANCREAS CANCER; PHYSICAL INACTIVITY; PREVALENCE; PRIORITY JOURNAL; PROSTATE CANCER; RISK FACTOR; RUSSIAN FEDERATION; SMOKING; SOUTH AMERICA; TUMOR GROWTH; WEIGHT CONTROL; WORLD HEALTH ORGANIZATION; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE;

DIABETES COMPLICATIONS; DIABETES MELLITUS; HUMANS; HYPOGLYCEMIC AGENTS; INCIDENCE; NEOPLASMS; WORLD HEALTH;

EID: 84901808296     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(14)60886-2     Document Type: Note

References (15)

1. International Diabetes Federation. IDF diabetes atlas update 2013. http://www.idf.org/diabetesatlas/introduction (accessed May 13, 2014).
2. Xu Y, Wang L, He J, et al. Prevalence and control of diabetes in Chinese adults. JAMA 2013; 310: 948-59.
3. WHO. Cancer fact sheet 297. http://www.who.int/mediacentre/factsheets/ fs297/en/ (accessed May 13, 2014).
4. Goss PE, Strasser-Weippl K, Lee-Bychkovsky BL, et al. Challenges to effective cancer control in China, India, and Russia. Lancet Oncol 2014; 15: 489-538.
5. Giovannucci E, Harlan DM, Archer MC, et al. Diabetes and cancer: a consensus report. Diabetes Care 2010; 33: 1674-85.
6. Kasper JS, Giovannucci E. A meta-analysis of diabetes mellitus and the risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2006; 15: 2056-62.
7. Bensimon L, Yin H, Suissa S, Pollak MN, Azoulay L. Type 2 diabetes and the risk of mortality among patients with prostate cancer. Cancer Causes Control 2014; 25: 329-38.
8. Seshasai SR, Kaptoge S, Thompson A, et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 2011; 364: 829-41.
9. Hu FB, Manson JE, Liu S, et al. Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst 1999; 91: 542-47.
10. Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ. Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol 2004; 159: 1160-67.
11. Le TN, Nestler JE, Strauss JF 3rd, Wickham EP 3rd. Sex hormone-binding globulin and type 2 diabetes mellitus. Trends Endocrinol Metab 2012; 23: 32-40.
12. Gallagher EJ, LeRoith D. Epidemiology and molecular mechanisms tying obesity, diabetes, and the metabolic syndrome with cancer. Diabetes Care 2013; 36 (suppl 2): S233-39.
13. Goodwin PJ, Pritchard KI, Ennis M, Clemons M, Graham M, Fantus IG. Insulin-lowering effects of metformin in women with early breast cancer. Clin Breast Cancer 2008; 8: 501-05.
14. Home P. Insulin therapy and cancer. Diabetes Care 2013; 36 (suppl 2): S240-44.
15. Vangoitsenhoven R, Mathieu C, Van der Schueren B. GLP1 and cancer: friend or foe? Endocr Relat Cancer 2012; 19: F77-88.